| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $120.3M | +10.4% |
| Cost of Revenue | $86.8M | +24.9% |
| R&D Expense | $7.3M | +81.2% |
| SG&A Expense | $22.6M | -21.4% |
| Operating Income | -$53.0M | -2603.3% |
| Pre-tax Income | -$52.6M | -897.5% |
| Income Tax | $12K | +107.3% |
| Net Income | -$52.6M | -929.8% |
| EPS (Basic) | -$1.27 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | -51.4% |
| Accounts Receivable | $15.0M | +0.7% |
| Inventory | $15.9M | -17.7% |
| Current Assets | $43.9M | -16.2% |
| Total Assets | $230.6M | -18.9% |
| Current Liabilities | $42.3M | -5.3% |
| Long-term Debt | $28.7M | +14.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -126.1% |
| Investing Cash Flow | -$8.2M | +90.4% |
| Financing Cash Flow | $3.7M | -91.3% |
| -807.1% |
| EPS (Diluted) | -$1.27 | -807.1% |
| Total Liabilities |
| $62.6M |
| -6.7% |
| Stockholders' Equity | $168.0M | -22.7% |